International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors

@article{Shimada2001InternationalNP,
  title={International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors},
  author={H. Shimada and S. Umehara and Y. Monobe and Y. Hachitanda and A. Nakagawa and S. Goto and R. Gerbing and D. Stram and J. Lukens and K. Matthay},
  journal={Cancer},
  year={2001},
  volume={92}
}
BACKGROUND The International Neuroblastoma Pathology Classification was established in 1999 for the prognostic evaluation of patients with neuroblastic tumors (NTs. [...] Key Method Then, prognostic significance of the International Classification for all NTs in four categories (neuroblastoma [NB]; ganglioneuroblastoma, intermixed [GNBi]; ganglioneuroma [GN]; and ganglioneuroblastoma, nodular [GNBn]) was analyzed.Expand
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors
The International Neuroblastoma Pathology Classification (International Classification), which was established in 1999, is significant prognostically and is relevant biologically for the evaluationExpand
Neuroblastoma: the association of anatomical tumour site, molecular biology and patient outcomes
TLDR
The association of anatomical site of NB with molecular biology and clinical outcomes is investigated and the importance of prognostic value in risk stratification of disease is investigated. Expand
Neuroblastoma: Tumor Biology and Its Implications for Staging and Treatment
TLDR
Current biologic principles used to stratify risk and guide treatment algorithms are discussed and the role for surgical resection in neuroblastoma is reviewed, including the indications and timing of surgery within the greater treatment plan. Expand
Revision of the International Neuroblastoma Pathology Classification
TLDR
Ganglioneuroblastoma, nodular can be divided into two prognostic subsets, a favorable subset (FS) and an unfavorable subset (US) of an unfavorable histology group. Expand
Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology
Neuroblastic tumor (NT) is the most common extracranial solid tumor of childhood with variable outcome which again depends on risk stratification related to distinct biology of the tumor. The use ofExpand
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients
Urinary catecholamine metabolites are well‐known to be elevated in patients with neuroblastoma. Some investigators have described different patterns in favorable and unfavorable cases. However,Expand
Comparative retrospective study on the modalities of biopsying peripheral neuroblastic tumors: a report from the Italian Pediatric Surgical Oncology Group (GICOP)
TLDR
This multi‐center study is to evaluate the accuracy and safety of the various examined techniques and to determine whether a preferential procedure exists for peripheral neuroblastic tumors. Expand
Management of Neuroblastoma in Pediatric Patients.
TLDR
The Children's Oncology Group, along with major international groups, uses the International Neuroblastoma Risk Group Staging System as a risk assessment tool. Expand
Peripheral neuroblastic tumors of the adrenal gland: clinicopathologic features and important molecular alterations
Abstract Peripheral neuroblastic tumors are the most common extracranial solid tumor of childhood and commonly present as an adrenal mass in a young child. This group of tumors is notable for wideExpand
Pathology of peripheral neuroblastic tumors
TLDR
In this article, prognostic significance and biological relevance of the International Neuroblastoma Pathology Classification (INPC) are described. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
The International Neuroblastoma Pathology Classification (the Shimada system)
The International Neuroblastoma Pathology Committee, which is comprised of six member pathologists, was convened with the objective of proposing a prognostically significant and biologically relevantExpand
Terminology and morphologic criteria of neuroblastic tumors
As part of the international cooperative effort to develop a complete set of International Neuroblastoma Risk Groups, the International Neuroblastoma Pathology Committee (INPC) initiated activitiesExpand
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular
TLDR
Ganglioneuroblastoma, nodular (GNBn) is a rare subtype of the family of neuroblastic tumors that are classified in the unfavorable histology group according to the International Neuroblastoma Pathology Classification (Shimada system). Expand
A proposed staging for children with neuroblastoma. Children's cancer study group A
TLDR
Short‐term survival data of this small sample demonstrated that the proposed staging appears to be of help in estimating the prognosis and a list of investigations which aid in accurate staging is proposed. Expand
Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group.
TLDR
The histopathologic findings in 420 patients with stage III and IV neuroblastoma enrolled in Childrens Cancer Study Group trials conducted from 1980 to 1983 show that outcome was related in a statistically significant manner to mitotic rate, multi-nuclearity, foam cells, ganglion cells, necrosis, and calcification, but only the latter was consistent for both stages. Expand
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
  • K. Matthay, C. Perez, +9 authors J. Lukens
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1998
TLDR
The excellent survival of the biologically favorable group and the historically improved EFS of the biological unfavorable group suggest that biologic staging should be used to define the prognosis and treatment of stage III neuroblastoma. Expand
Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.
Histopathologic prognostic factors of 295 pretreatment tumors of a total 641 neuroblastomas and ganglioneuroblastomas were studied with the use of the following proposed tumor classification. TheExpand
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
TLDR
This study confirms the favorable biologic features and excellent survival of infants with stage IV-S neuroblastoma with minimal therapy. Expand
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
  • C. Perez, K. Matthay, +6 authors J. Lukens
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
TLDR
Children with stages I and II neuroblastoma have 98% survival with surgery alone as primary therapy and a subset of patients at higher risk for death can be defined as those with stage II disease who have tumor MYCN amplification or who are >/= 2 years of age with either unfavorable histopathology or positive lymph nodes. Expand
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
TLDR
The data suggest that surgery alone, even if complete resection is not achieved, is sufficient initial therapy for stage II neuroblastoma, in addition to stage IV-S, for which almost all patients have a favorable prognosis. Expand
...
1
2
3
...